SMED - Earnings announcements

Third quarter revenue of $17.6 million decreased 36% compared to the prior year; Excluding COVID-19 related immunization activity, third quarter revenue increased 24%Route-based customer locations increased 21% to 18,600 from 15,400 in the prior year; billings increased 12%Professional market billings grew 19% compared to prior year third quarterHome Healthcare billings increased 21% compared to third quarter 2021 Third quarter immunization-related mailback billings of $2.9 million decreased as compared to $20.2 million in third quarter 2021; Increased substantially over pre-COVID levels of $0.7 million in third quarter 2020 MedSafe billings increased 19% to $1.5 million from $1.2 million in

HOUSTON, April 26, 2022 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ:SMED) announced today that it has rescheduled the release of its third quarter 2022 financial results. The Company will release third quarter 2022 results for the period ended March 31, 2022, before the opening of the financial markets on Thursday, May 12, 2022. A conference call and webcast will follow at 11:00 a.m. ET, in which management will discuss the Company's financial results, key market initiatives and business strategy. The Sharps Compliance conference call can be accessed by domestic callers by dialing (877) 545-0320. International callers may access the call by dialing (973) 528-0002. Callers should

HOUSTON, April 19, 2022 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ:SMED) announced today that it will release its third quarter 2022 results for the period ended March 31, 2022, before the opening of the financial markets on Wednesday, April 27, 2022. A conference call and webcast will follow at 11:00 a.m. ET, in which management will discuss the Company's financial results, key market initiatives and business strategy. The Sharps Compliance conference call can be accessed by domestic callers by dialing (877) 545-0320. International callers may access the call by dialing (973) 528-0002. Callers should use conference entry code 797852. The webcast can be monitored at www.sharpsinc

Second quarter revenue of $18.9 million increased 11% from the prior year and 36% sequentiallyRoute-based customer locations increased 17% to 17,400 from 14,900 in the prior yearProfessional market billings grew 15% compared to prior year second quarterUnused medication revenue increased 9% driven by increased Inner Liner salesImmunization-related mailback billings increased by $2.8 million sequentially as compared to 1Q22, from $1.8 million to $4.6 million, reflecting COVID-19 vaccines and booster shots administered in the Retail Pharmacy marketClosed on Affordable Medical Waste acquisition on October 22, 2021Partnership with PharMerica recently announced to address the cost-effective and c

HOUSTON, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ:SMED) announced today that it will release its second quarter 2022 results for the period ended December 31, 2021, before the opening of the financial markets on Wednesday, January 26, 2022. A conference call and webcast will follow at 11:00 a.m. ET, in which management will discuss the Company's financial results, key market initiatives and business strategy. The Sharps Compliance conference call can be accessed by domestic callers by dialing (888) 506-0062. International callers may access the call by dialing (973) 528-0011. Callers should use conference entry code 618730. The webcast can be monitored at www.shar

HOUSTON, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ:SMED) announced today that it will release its first quarter 2022 results for the period ended September 30, 2021, before the opening of the financial markets on Wednesday, October 27, 2021. A conference call and webcast will follow at 11:00 a.m. ET, in which management will discuss the Company's financial results, key market initiatives and business strategy. The Sharps Compliance conference call can be accessed by domestic callers by dialing (888) 506-0062. International callers may access the call by dialing (973) 528-0011. Callers should use conference entry code 896291. The webcast can be monitored at www.shar

Fourth Quarter Revenue of $18.7 million and full year 2021 Revenue of $76.4 million, each increased 49% from the prior year Fourth Quarter Customer Billings1 of $18.7 million, increased 38% over the prior yearRetail market billings increased 68% for the quarter and 153% for the yearProfessional market billings grew 44% for the quarter and 15% for the yearRoute-Based Pickup billings increased 31% for the quarter and 32% for the yearMailback billings grew 68% to $12.0 million for the quarter, driven by strong immunization related orders, and grew 93% for the yearFourth Quarter Net Income of $5.1 million, or $0.29 per diluted share and full year Net Income of $12.9 million, or $0.76 per diluted

HOUSTON, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ:SMED) announced today that it will release its fourth quarter 2021 results for the period ended June 30, 2021, before the opening of the financial markets on Wednesday, August 18, 2021. A conference call and webcast will follow at 11:00 a.m. ET, in which management will discuss the Company's financial results, key market initiatives and business strategy. The Sharps conference call can be accessed by domestic callers by dialing (877) 407-0782. International callers may access the call by dialing (201) 689-8567. The webcast can be monitored at www.sharpsinc.com. A telephonic replay will be available through Septemb